arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2209.03352cs.LGcs.AI

用于医疗器械风险评估与管理的混合贝叶斯网络

A hybrid Bayesian network for medical device risk assessment and management

Queen Mary University of London(伦敦玛丽女王大学);Agena Ltd(阿格娜有限公司)

Joshua Hunte, Martin Neil, Norman Fenton

AI总结:

提出一种基于混合贝叶斯网络的医疗器械风险管理方法,克服FTA等传统方法在数据有限或存在二阶不确定性时的局限,并在除颤器设备上验证了其有效性。

摘要:

ISO 14971是用于医疗器械风险管理的主要标准。虽然它规定了医疗器械风险管理的要求,但并未指定执行风险管理的具体方法。因此,医疗器械制造商可以自由开发或使用任何适当的方法来管理医疗器械的风险。最常用的方法,如故障树分析(FTA),在历史数据有限或没有历史数据,或者对数据存在二阶不确定性的情况下,无法为计算风险估计值提供合理的基础。在本文中,我们提出了一种使用混合贝叶斯网络(BNs)进行医疗器械风险管理的新方法,该方法解决了FTA等经典方法的局限性,并纳入了影响医疗器械风险的相关因素。提出的BN方法是通用的,但可以基于系统逐一实例化,我们将其应用于除颤器设备,以演示在生产和生产后阶段医疗器械风险管理所涉及的过程。该示例已通过真实世界数据的验证。

英文摘要:

ISO 14971 is the primary standard used for medical device risk management. While it specifies the requirements for medical device risk management, it does not specify a particular method for performing risk management. Hence, medical device manufacturers are free to develop or use any appropriate methods for managing the risk of medical devices. The most commonly used methods, such as Fault Tree Analysis (FTA), are unable to provide a reasonable basis for computing risk estimates when there are limited or no historical data available or where there is second-order uncertainty about the data. In this paper, we present a novel method for medical device risk management using hybrid Bayesian networks (BNs) that resolves the limitations of classical methods such as FTA and incorporates relevant factors affecting the risk of medical devices. The proposed BN method is generic but can be instantiated on a system-by-system basis, and we apply it to a Defibrillator device to demonstrate the process involved for medical device risk management during production and post-production. The example is validated against real-world data.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑